← Open Payments lookup

CASANDRA MOYER: Open Payments

NPI 1891162384 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$348 in 11 payments from 6 companies in 2025. Trend: 2023 $382 · 2024 $179 · 2025 $348

Food & beverage: $348
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$159
Janssen Pharmaceuticals, Inc3$59
Otsuka America Pharmaceutical, Inc.2$45
E.R. Squibb & Sons, L.L.C.2$44
ABBVIE INC.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: INGREZZA, INVEGA SUSTENNA, REXULTI, COBENFY, VRAYLAR, CAPLYTA.

Industry payments across CA — which companies pay providers there.